drugset / Trial / NCT00043771
Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
Patients with congestive heart failure will be assessed for safety and clinical effects of Tolvaptan 30 mg every day versus 15 mg twice a day over a period of 7 days.
Timeline
- Start
- 2002-05
- Primary completion
- —
- Completion
- 2002-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tolvaptan | Unknown | 15 mg | — |
| Subject | Tolvaptan | Unknown | 30 mg | — |